Observations placeholder
Invanz
Identifier
019209
Type of Spiritual Experience
Number of hallucinations: 119
Background
A description of the experience
Ertapenem is a carbapenem antibiotic marketed as Invanz. It is structurally very similar to meropenem in that it possesses a 1-β-methyl group. Other members of the carbapenem group (imipenem, doripenem, and meropenem) are broadly active antibacterials that are used for infections caused by difficult to treat or multidrug-resistant bacteria (such as ESBL expressing Klebsiella pneumonia). They have very short serum half-lives and must be administered by intravenous infusion every 6 to 8 hours. Ertapenem differs from other carbapenems in having a somewhat less broad spectrum of activity (not against Pseudomonas aeruginosa), and in that its extended serum half-life allows it to be administered once every 24 hours
On Dec, 19, 2016 2,287 people reported to have side effects when taking Invanz.
Among them, 119 people (5.2%) have Hallucination
Time on Invanz when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 95.92% | 4.08% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Dec, 31, 2015: 1,512 people reported to have side effects when taking Invanz. Among them, 89 people (5.89%) have Death.
Time on Invanz when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 88.57% | 11.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |